Inhibition of MYC suppresses programmed cell death ligand-1 expression and enhances immunotherapy in triple-negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of MYC suppresses programmed cell death ligand-1 expression and enhances immunotherapy in triple-negative breast cancer

Published:2022-10-20 Issue:20 Volume:135 Page:2436-2445
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Li Xintong,Tang Lin,Chen Qin,Cheng Xumin,Liu Yiqiu,Wang Cenzhu,Zhu Chengjun,Xu Kun,Gao Fangyan,Huang Jinyi,Wang Runtian,Guan Xiaoxiang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference44 articles.

1. Cancer incidence and mortality in Zhejiang Province, Southeast China, 2016: a population-based study;Wang;Chin Med J,2021

2. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020;Cao;Chin Med J,2021

3. Molecular alterations in triple-negative breast cancer-the road to new treatment strategies;Denkert;Lancet,2017

4. Triple-negative breast cancer: treatment challenges and solutions;Collignon;Breast Cancer (Dove Med Press),2016

5. Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy;Bai;Chin Med J,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDK7 in breast cancer: mechanisms of action and therapeutic potential;Cell Communication and Signaling;2024-04-11

2. Nucleic acid vaccines‐based therapy for triple‐negative breast cancer: A new paradigm in tumor immunotherapy arena;Cell Biochemistry and Function;2024-03-29

3. Estrogen receptor beta suppresses the androgen receptor oncogenic effects in triple-negative breast cancer;Chinese Medical Journal;2023-12-15

4. Synthesis and mechanism of action of new purine derivatives against triple negative breast cancer;European Journal of Medicinal Chemistry;2023-12

5. Ultrasound-responsive spherical nucleic acid against c-Myc/PD-L1 to enhance anti-tumoral macrophages in triple-negative breast cancer progression;Science China Life Sciences;2023-11-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3